1. bookVolume 21 (2013): Issue 3 (September 2013)
Journal Details
License
Format
Journal
eISSN
2284-5623
ISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Prenatal diagnosis of 21 trisomy by quantification of methylated fetal DNA in maternal blood: study on 10 pregnancies

Journal Details
License
Format
Journal
eISSN
2284-5623
ISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Background. The Down syndrome is a severe disease without pathogenic therapy. The only possibility to reduce the consequences of disease is prenatal screening and diagnosis. The gold standard in prenatal diagnosis is the conventional banding cytogenetic analysis of fetal cells obtained by invasive procedures. To reduce the complications, in the last years different methods to detect fetal cells or DNA in maternal blood were developed. Aim. The aim of study was to verify the reliability of quantification by immunoprecipitation of methylated fetal DNA in maternal blood in the prenatal diagnosis of 21 trisomy. Method. We analyzed probes from 12 pregnant women (7 with confirmed 21 trisomy pregnancy and 5 with normal pregnancy), with two being rejected for technical considerations. For each probe we carried out: extraction of total DNA (maternal and fetal), DNA fragmentation, immunoprecipitation of methylated DNA, washing, isolation of DNA and qPCR for immunoprecipitated DNA. To highlighting specific methylated regions on fetal 21 chromosome we used eight pairs of specific primers for chromosome 21. Finally we analysed the results of qPCR applying the formula D=- 6.331+0.959XEP4+1.188XEP5+0.424XEP6+0.621XEP7+0.028XEP8+0.387XEP10-0.683XEP11+ 0.897XEP12, where XEPi= fraction value for each marker. Results. In all normal pregnancies the value of D factor was negative concordant with absence of trisomy (100% specificity). In 5 from 6 pregnancies with 21 trisomy the value of D factor was positive, which indicated a high sensibility. However, to a precise estimation of this method is required a larger number of cases that allowing the obtaining of statistically validated results.

Keywords

Cuvinte cheie

1. Gorduza EV, Covic M, Stoica O, Voloşciuc M, Angheloni T, Butnariu L, et al. Studii clinice, epidemiologice şi citogenetice pe un lot de 221 pacienţi cu sindrom Down. Rev Med Chir Soc Med Nat Iasi. 2007 Apr- Jun;111(2):363-72.Search in Google Scholar

2. Popovici C, Ştefănescu D, Mixitch F, Gug C, Covic M. Profilaxia bolilor genetice. Covic M, Ştefănescu D, Sandovici I (Eds.), Genetică Medicală, 2nd Ed. Polirom Iaşi, 2011:619-646Search in Google Scholar

3. Gekas J, van den Berg DG, Durand A, Vallée M, Wildschut HI, Bujold E, et al. Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnor- malities. Eur J Hum Genet. 2011 Jan;19(1):3-9.10.1038/ejhg.2010.138Search in Google Scholar

4. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27(1):1-710.1159/000271995Search in Google Scholar

5. Faas BH, Cirigliano V, Bui TH. Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies. Semin Fetal Neonatal Med. 2011 Apr;16(2):81-7.10.1016/j.siny.2011.01.003Search in Google Scholar

6. Gorduza EV, Onofriescu M, Martiniuc V, Grigore M, Mihălceanu E, Iliev G. Importanţa tehnicii FISH în diagnosticul prenatal al aneuploidiilor. Rev Med Chir Soc Med Nat Iasi. 2007 Oct-Dec;111(4):990-996Search in Google Scholar

7. Hahn S, Yan Zhong X, Holzgreve W. Recent progress in non-invasive prenatal diagnosis. Semin Fetal Neonatal Med. 2008 Apr;13(2):57-62.10.1016/j.siny.2007.11.001Search in Google Scholar

8. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet. 1997 Oct;61(4):822-9.10.1086/514885Search in Google Scholar

9. Bianchi DW, Simpson JL, Jackson LG, Elias S, Holzgreve W, Evans MI, et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn. 2002 Jul;22(7):609-15.10.1002/pd.347Search in Google Scholar

10. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 2007 Mar;581(5):795-9.10.1016/j.febslet.2007.01.051Search in Google Scholar

11. Bischoff FZ, Lewis DE, Simpson JL. Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update. 2005 Jan-Feb;11(1):59-67.10.1093/humupd/dmh053Search in Google Scholar

12. Dennis Lo YM, Chiu RW. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet. 2007 Jan;8(1):71-7.10.1038/nrg1982Search in Google Scholar

13. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem. 1999 Feb;45(2):184-8.10.1093/clinchem/45.2.184Search in Google Scholar

14. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. Maternal plasma fetal DNA as a marker for preterm labour. Lancet. 1998 Dec;352(9144):1904-5.10.1016/S0140-6736(05)60395-9Search in Google Scholar

15. Lau TK, Lo KW, Chan LY, Leung TY and Lo YM. Cell-free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal maternal hemorrhage in patients undergoing external cephalic version near term. Am J Obstet Gynecol. 2000 Sep; 183(3):712-716.10.1067/mob.2000.106582Search in Google Scholar

16. Zhong XY, Holzgreve W, Li JC, Aydinli K, Hahn S. High levels of fetal erythroblasts and fetal extracellular DNA in the peripheral blood of a pregnant woman with idiopathic polyhydramnios: case report. Prenat Diagn. 2000 Oct;20(10):838-41.10.1002/1097-0223(200010)20:10<838::AID-PD911>3.0.CO;2-PSearch in Google Scholar

17. Zhong XY, Bürk MR, Troeger C, Jackson LR, Holzgreve W, Hahn S. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn. 2000 Oct;20(10):795-8.10.1002/1097-0223(200010)20:10<795::AID-PD897>3.0.CO;2-PSearch in Google Scholar

18. Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem. 2004 Jan;50(1):88-92.10.1373/clinchem.2003.024893Search in Google Scholar

19. van Lith JM, Benacerraf BR, Yagel S. Current controversies in prenatal diagnosis 2: Down syndrome screening: is ultrasound better than cell-free nucleic acids in maternal blood? Prenat Diagn. 2011 Mar;31(3):231-4.10.1002/pd.2681Search in Google Scholar

20. Chim SS, Tong YK, Chiu RW, Lau TK, Leung TN, Chan LY, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A. 2005 Oct;102(41):14753-8.10.1073/pnas.0503335102Search in Google Scholar

21. Fan HC, Quake SR. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS One. 2010 May;5(5):e10439.10.1371/journal.pone.0010439Search in Google Scholar

22. Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, Lamnissou K, et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol. 2009 May;174(5):1609-18.10.2353/ajpath.2009.081038Search in Google Scholar

23. Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med. 2011 Apr;17(4):510-3.10.1038/nm.2312Search in Google Scholar

24. Papageorgiou EA, Patsalis PC. Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications. Genome Med. 2012 May;4(5):46.10.1186/gm345Search in Google Scholar

25. Tong YK, Chiu RW, Chan KC, Leung TY, Lo YM. Technical concerns about immunoprecipitation of methylated fetal DNA for noninvasive trisomy 21 diagnosis. Nat Med. 2012 Sep;18(9):1327-8.10.1038/nm.2915Search in Google Scholar

26. Norton ME, Rose NC, Benn P., Noninvasive prenatal testing for fetal aneuploidy: Clinical assessment and a plea for restraint, Obstet. Gynecol., 2013 April; 121(4): 847-85010.1097/AOG.0b013e31828642c6Search in Google Scholar

27. Nicolaides KH, Syngelaki A, Ashoor G, Birdir C., Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207:374.e1-610.1016/j.ajog.2012.08.033Search in Google Scholar

28. Morain S, Greene MF, Mello MM., A New Era in Noninvasive Prenatal Testing, N Engl J Med. 2013 Jul 17, 1-4 DOI: 10.1056/NEJMp1304843. 10.1056/NEJMp1304843Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo